On ECHEMI
Home > Drugs > Lichen planus
Lichen planus
Lichen planus is a skin and mucosal disease with superficial lesions and slow development. It can occur alone or simultaneously on the skin and oral mucosa. It is more common in middle-aged women.
  • Site of disease:

    mouth
  • Infectious :

    Not contagious
  • Frequent population:

    All people, mostly middle-aged women
  • Related symptoms:

    Mucosal congestion abnormal ichthyosis pimples pimples congestion
  • Concurrent disease:

Related Drugs
Triamcinolone acetonide acetate urea cream
Indication: For the symptomatic treatment of psoriasis and lichen planus.
Manufacturer:

Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.

Triamcinolone acetonide acetate urea cream
Indication: This product is used for the symptomatic treatment of lichen planus.
Manufacturer:

Tianjin Pacific Pharmaceutical Co., Ltd.

Triamcinolone acetonide acetate urea cream
Indication: This product is used for the symptomatic treatment of lichen planus.
Manufacturer:

Guangzhou Baiyunshan Pharmaceutical Co.,ltd.baiyunshan Hejigong Pharmaceutical Factory

Triamcinolone acetonide acetate urea cream
Indication: This product is used for the symptomatic treatment of lichen planus.
Manufacturer:

Beijing Shuguang Pharm Co., Ltd.

Triamcinolone acetonide acetate urea cream
Indication: This product is used for the symptomatic treatment of lichen planus.
Manufacturer:

Guangxi LMZ Yikang Pharmaceutical Co., Ltd.

Triamcinolone acetate urea cream
Indication: This product is used for the symptomatic treatment of lichen planus.
Manufacturer:

Changzhou Siyao Pharmaceuticals Co., Ltd.

DEPO-MEDROL- methylprednisolone acetate_injection, suspension
Indication: INDICATIONS AND USAGE
When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of DEPO-MEDROL Sterile Aqueous Suspension is indicated as follows: Allergic States: Dermatologic Diseases Endocrine Disorders: Gastrointestinal Diseases: Hematologic Disorders: Miscellaneous: Neoplastic Diseases: Nervous System: Ophthalmic Diseases: Renal Diseases: Respiratory Diseases: Rheumatic Disorders: (see WARNINGS DEPO-MEDROL is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis of osteoarthritis. DEPO-MEDROL is indicated for intralesional use in alopecia areata, discoid lupus erythematosus, keloids, localized hypertrophic, infiltrated, inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus (neurodermatitis), and psoriatic plaques, necrobiosis lipoidica diabeticorum.
A. FOR INTRAMUSCULAR ADMINISTRATION
When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of DEPO-MEDROL Sterile Aqueous Suspension is indicated as follows: Allergic States: Dermatologic Diseases Endocrine Disorders: Gastrointestinal Diseases: Hematologic Disorders: Miscellaneous: Neoplastic Diseases: Nervous System: Ophthalmic Diseases: Renal Diseases: Respiratory Diseases: Rheumatic Disorders:
B. FOR INTRA-ARTICULAR OR SOFT TISSUE ADMINISTRATION
(see WARNINGS DEPO-MEDROL is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis of osteoarthritis.
C. FOR INTRALESIONAL ADMINISTRATION
DEPO-MEDROL is indicated for intralesional use in alopecia areata, discoid lupus erythematosus, keloids, localized hypertrophic, infiltrated, inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus (neurodermatitis), and psoriatic plaques, necrobiosis lipoidica diabeticorum.
Manufacturer:

A-S Medication Solutions

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.